DCA Cancels Licences Of Two Blood Banks For Illegal Sale Of Human Plasma

Hyderabad: VB Kamalasan Reddy (IPS), Director General said in a press release that “On 2nd February 2024, officers from the Drugs Control Administration, Telangana, acting on credible information, conducted a raid at ‘Haemo Service Laboratories’ situated in a residential building at Door No. 11-5-176, Bhavani Nagar, Moosapet, Hyderabad. During the raid, DCA officers detected a huge stock of human plasma bags stored in freezers. R. Raghavendra Naik has been operating the firm ‘Haemo Service laboratories’ within the apartment, illegally collecting plasma from various blood banks (blood centers), and stockpiling them for sale in an unauthorized manner.

DCA officers found that ‘Srikara Hospital Blood Bank’ in Mythri Nagar, Madinaguda, Miyapur, Ranga Reddy District, and the ‘New Life Educational Society Blood Centre’ at Abid Ali Khan Lions Eye Hospital, Darulshifa, Hyderabad, illegally sold plasma to R. Raghavendra Naik of Haemo Service Laboratories, not adhering to the norms.

DCA officers immediately raided Srikara Hospital Blood Centre (A Unit of Venkateshwara Ortho Health Care Pvt. Ltd.), situated at D.No.222 & 223, 5th floor, Mythri Nagar, Phase-II, Madinaguda, Miyapur, Rangareddy District, and New Life Educational Society Blood Centre, situated at D. No. 22-1-1038, First floor, Abid Ali Khan Lion Eye Hospital, Darulshifa, Hyderabad, and confirmed the illegal sale of plasma to ‘Haemo Service Laboratories’ upon verification.

At blood banks, plasma is separated from whole blood, collected from donors, through a process called ‘plasmapheresis’. After collection, it must be frozen within 6 hours to preserve its integrity. Plasma must be stored in freezers at temperatures below minus 30°C to maintain its stability and prevent degradation.

Human plasma plays a crucial role in various medical treatments and therapies. Plasma transfusions are essential in treating patients with clotting disorders, such as hemophilia, and those who have undergone massive blood loss or trauma and also used in the treatment of immunodeficiency disorders and autoimmune diseases. Plasma is also administered to patients in critical conditions, such as severe burns, to stabilize their condition and prevent complications.

DCA Telangana issued show cause notices to ‘Srikara Hospital Blood Centre’ in Madinaguda, Miyapur, and ‘New Life Educational Society Blood Centre’ in Darulshifa, Hyderabad, following inspections of the blood banks (blood centers). The notices were issued regarding the illegal sale of plasma from the blood bank and for certain violations reported by DCA officers regarding non-conformity with blood bank norms.

As the illegal sale of plasma by blood banks can have detrimental consequences on public health, the licenses of the two blood banks, ‘Srikara Hospital Blood Centre’ in Madinaguda, Miyapur, and ‘New Life Educational Society Blood Centre’ in Darulshifa, Hyderabad, have been cancelled by the Drugs Control Administration, Telangana, with immediate effect, in the larger public interest.

Blood banks (blood centers) must implement stringent measures to prevent such activities and ensure the integrity of blood banking practices. Stringent action shall be taken as per the law against violators.

Related Posts

  • Pharma
  • July 16, 2025
  • 133 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 42 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients